$7.04
0.86% today
Nasdaq, Feb 28, 04:43 pm CET
ISIN
KYG596651029
Symbol
MGTX
Sector
Industry

MeiraGTx Holdings plc Stock price

$6.98
+0.80 12.95% 1M
+2.89 70.66% 6M
+0.89 14.61% YTD
+0.82 13.31% 1Y
-7.35 51.29% 3Y
-8.79 55.74% 5Y
-8.02 53.47% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-0.33 4.51%
ISIN
KYG596651029
Symbol
MGTX
Sector
Industry

Key metrics

Market capitalization $545.51m
Enterprise Value $509.38m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 36.57
P/S ratio (TTM) P/S ratio 39.16
P/B ratio (TTM) P/B ratio 5.66
Revenue (TTM) Revenue $13.93m
EBIT (operating result TTM) EBIT $-176.48m
Free Cash Flow (TTM) Free Cash Flow $-102.53m
Cash position $122.87m
EPS (TTM) EPS $-1.31
P/E forward negative
P/S forward 33.03
EV/Sales forward 30.84
Short interest 3.65%
Show more

Is MeiraGTx Holdings plc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

MeiraGTx Holdings plc Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a MeiraGTx Holdings plc forecast:

6x Buy
100%

Analyst Opinions

6 Analysts have issued a MeiraGTx Holdings plc forecast:

Buy
100%

Financial data from MeiraGTx Holdings plc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
14 14
67% 67%
100%
- Direct Costs 26 26
209% 209%
184%
-12 -12
135% 135%
-84%
- Selling and Administrative Expenses 22 22
101% 101%
157%
- Research and Development Expense 129 129
66% 66%
927%
-163 -163
117% 117%
-1,169%
- Depreciation and Amortization 14 14
65% 65%
98%
EBIT (Operating Income) EBIT -176 -176
112% 112%
-1,267%
Net Profit -88 -88
21% 21%
-633%

In millions USD.

Don't miss a Thing! We will send you all news about MeiraGTx Holdings plc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

MeiraGTx Holdings plc Stock News

Neutral
GlobeNewsWire
7 days ago
LONDON and NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced the publication of results from the first-in-human interventional study to treat children with AIPL1-associated severe retinal dystrophy. The data were published in The Lancet in a paper titled, "Gene therapy in children ...
Positive
Seeking Alpha
about one month ago
MeiraGTx Holdings plc is advancing AAV-AIPL1 for AIPL1-associated Leber congenital amaurosis 4, with a near-term BLA filing in the UK under Exceptional Circumstance possible. Bota-vec, developed with Janssen, could see a BLA filing for X-linked Retinitis Pigmentosa in 2025. Initiation of phase 3 study, using AAV-GAD for the treatment of patients with Parkinson's Disease, expected in 2025.
Neutral
GlobeNewsWire
about one month ago
MeiraGTx has recently received Rare Pediatric Disease Designation (RPDD) for four inherited retinal diseases (IRDs) reflecting the transformative therapeutic potential of the Company's proprietary technology platforms MeiraGTx has recently received Rare Pediatric Disease Designation (RPDD) for four inherited retinal diseases (IRDs) reflecting the transformative therapeutic potential of the Comp...
More MeiraGTx Holdings plc News

Company Profile

MeiraGTx Holdings Plc is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1 and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY.

Head office Cayman Islands
CEO Alexandria Forbes
Employees 425
Founded 2015
Website www.meiragtx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today